openPR Logo
Press release

Molecular Diagnostics Market to Reach USD 33.2 Billion by 2035, Driven by Personalized Medicine and Growing Demand for At-Home Testing

09-26-2025 09:40 AM CET | Health & Medicine

Press release from: MarketGenics India Pvt. Ltd.

Molecular Diagnostics Market to Reach USD 33.2 Billion by 2035, Driven by Personalized Medicine and Growing Demand for At-Home Tes

Molecular Diagnostics Market to Reach USD 33.2 Billion by 2035, Driven by Personalized Medicine and Growing Demand for At-Home Tes

Molecular Diagnostics Market to Reach USD 33.2 Billion by 2035, Driven by Personalized Medicine and Rise of At-Home Testing

Molecular Diagnostics Market projected to grow at a CAGR of 6.6% during the forecast period of 2025 to 2035

MarketGenics, a leading name in healthcare research, announced a series of milestones in the rapidly growing Molecular Diagnostics Market globally.
The market insights highlight cutting-edge innovation, affordability, and accessibility, signaling a transformative shift toward personalized and preventative healthcare.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Molecular Diagnostics Market Research Report: https://marketgenics.co/press-releases/molecular-diagnostics-market-21235

Recent Strategic Partnership - May 2025: Danaher Corporation announced a partnership with AstraZeneca to develop AI-powered precision diagnostic tools through its new Centers for Enabling Precision Medicine, integrating research, development, and commercialization under one roof.

Digital Pathology Expansion - June 2025: Roche Diagnostics expanded its navify Digital Pathology platform with over 20 AI-based algorithms, aimed at improving cancer diagnosis and supporting personalized treatments worldwide.

At-Home Testing Push - Early 2025: Cue Health launched expanded molecular COVID-19 and flu home-testing kits, highlighting the rising trend of accessible, non-invasive testing solutions.

To know more about the Molecular Diagnostics Market - Download our Sample Report: https://marketgenics.co/download-report-sample/molecular-diagnostics-market-21235

Molecular Diagnostics Market Forecast 2035

According to the report, the global molecular diagnostics market is expected to grow from USD 16.5 Billion in 2025 to USD 33.2 Billion in 2035, registering a CAGR of 6.6% during the forecast period.

The growth is driven by:

Increasing focus on personalized medicine and precision diagnostics.

Rising demand for at-home and point-of-care molecular testing.

Technological advancements such as liquid biopsy and next-generation sequencing (NGS).

Greater healthcare accessibility in emerging markets.

For instance, Guardant Health's liquid biopsy portfolio gained significant traction in early colorectal cancer detection in 2025, signaling a growing shift toward non-invasive cancer diagnostics.

Key Driver, Restraint, and Growth Opportunity Shaping the Global Molecular Diagnostics Market

Drivers - Precision Medicine and Accessibility Fueling Market Growth

The market's growth is anchored by three core drivers:

Shift toward precision medicine: Personalized care is becoming mainstream, with molecular diagnostics enabling early detection and customized treatment plans, especially in cancer, infectious diseases, and genetic disorders.

Cost-effectiveness: Advances in manufacturing and streamlined production have made molecular testing more affordable, increasing adoption in low- and middle-income countries.

Provider and patient acceptance: Clinicians and patients now prefer less invasive, rapid tests, reducing delays in diagnosis and enabling better treatment outcomes.

Buy Now: https://marketgenics.co/buy/molecular-diagnostics-market-21235

Restraints - High Costs and Regulatory Challenges

Developing and manufacturing advanced molecular diagnostic tests remains expensive, restricting smaller companies from entering the market.

Regulatory hurdles, such as extensive clinical validation requirements, slow down the approval process for new tests.

Clinical adoption may be delayed as healthcare professionals remain cautious about replacing well-established traditional tests with newer technologies.

Opportunities - Personalized, Affordable, and Long-Term Care

Rising global demand for affordable precision diagnostics is creating opportunities for companies offering innovative, user-friendly testing kits.

A shift away from one-size-fits-all treatments toward targeted, long-term care plans opens new revenue streams for molecular diagnostics.

Governments and hospitals are investing heavily in preventive healthcare, expanding access to advanced diagnostic solutions worldwide.

Key Trend: Growth of Rapid and At-Home Testing
The molecular diagnostics market is witnessing strong growth in at-home testing kits and point-of-care solutions, driven by demand for quick, accurate, and non-invasive diagnostics.

PCR-based and next-generation sequencing tests are increasingly being integrated with digital health platforms to enable real-time reporting and monitoring.

Government initiatives are further supporting the deployment of low-cost testing options in underserved communities.

Get a preview of our Molecular Diagnostics Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/molecular-diagnostics-market-21235

Expansion of Global Molecular Diagnostics Market

"Reagents & Kits Driving Market Dominance"

The Reagents & Kits segment accounts for ~63% market share, making it the largest category in 2025.

These products are essential for diagnostic techniques such as PCR, real-time PCR, and NGS used in detecting cancer, genetic disorders, and infectious diseases.

Demand for customized and automated reagent kits is expected to rise as personalized medicine and routine screening programs expand globally.

Regional Analysis of Global Molecular Diagnostics Market
North America - Market Leader

North America dominates the global molecular diagnostics market, driven by regulatory clarity, robust innovation, and strong healthcare demand.

The U.S. FDA has approved 71+ molecular diagnostic products by late 2024, creating a favorable environment for rapid commercialization.

The region is expected to account for ~41% of the global market by 2025.

Europe - Rising Government Support

European countries are expanding access through public healthcare initiatives and subsidies, accelerating the adoption of advanced molecular diagnostic tools.

Asia Pacific - High-Growth Region

Growth is fueled by increased healthcare spending, rising disease prevalence, and rapid infrastructure development.

The region is emerging as a key target for affordable diagnostic solutions and home-testing kits.

Recent Developments

May 2025: Danaher and AstraZeneca launch Centers for Enabling Precision Medicine, combining AI-driven diagnostics with advanced pathology research.

June 2025: Roche integrates 20 new AI algorithms into its navify platform, revolutionizing cancer detection and personalized treatment options.

Early 2025: Cue Health expands its at-home molecular COVID-19 and flu testing kits, meeting growing consumer demand for home-based diagnostics.

Prominent Players in the Molecular Diagnostics Market

Key players operating in the global molecular diagnostics market include:

Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Cepheid), Qiagen N.V., Illumina Inc., Hologic Inc., Agilent Technologies, Bio-Rad Laboratories, Exact Sciences Corporation, Myriad Genetics, Natera Inc., Siemens Healthineers, Sysmex Corporation, Oxford Nanopore Technologies, and Other Key Players.

The market is moderately consolidated, with Tier 1 companies like Roche, Thermo Fisher, Abbott, and Danaher holding significant global market share, while Tier 2 and Tier 3 players focus on niche segments and regional markets.

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

Contact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Molecular Diagnostics Market to Reach USD 33.2 Billion by 2035, Driven by Personalized Medicine and Growing Demand for At-Home Testing here

News-ID: 4199110 • Views:

More Releases from MarketGenics India Pvt. Ltd.

Neurostimulation Devices Market to Reach USD 35.8 Billion by 2035, Fueled by AI-Driven Therapies and Rising Demand for Minimally Invasive Neurological Treatments
Neurostimulation Devices Market to Reach USD 35.8 Billion by 2035, Fueled by AI- …
Neurostimulation Devices Market is projected to reach USD 35.8 Billion by 2035 Neurostimulation Devices Market projected to grow at a highest CAGR of 11.2% during the forecast period of 2025 to 2035 MarketGenics, a leading name in healthcare research, announced a series of milestones in the rapidly expanding Neurostimulation Devices Market globally. The market insights highlight technological innovation, minimally invasive treatments, and enhanced neurological care solutions as key pillars of growth. Get the Detailed
Nutraceuticals and Dietary Sup Market to Reach USD 865 Billion by 2035, Driven by Personalized Nutrition and Preventive Health Trends
Nutraceuticals and Dietary Sup Market to Reach USD 865 Billion by 2035, Driven b …
Nutraceuticals and Dietary Sup Market to Reach USD 865 Billion by 2035, Driven by Preventive Health and Personalized Nutrition MarketGenics, a leading name in health and wellness industry insights, announced a series of milestones in the rapidly growing global nutraceuticals and dietary sup market. The market outlook highlights robust growth fueled by rising preventive healthcare trends, demand for personalized nutrition, and the integration of innovative product formats such as functional beverages, plant-based
Omega-3 Market to Reach USD 6.1 Billion by 2035, Driven by Sustainable, Vegan-Friendly Algal Alternatives
Omega-3 Market to Reach USD 6.1 Billion by 2035, Driven by Sustainable, Vegan-Fr …
Omega-3 Market is Projected to Reach USD 6.1 Billion by 2035 Omega-3 Market expected to grow at a CAGR of 7.2% during the forecast period of 2025 to 2035 MarketGenics, a leading name in nutrition and health industry insights, announced a series of milestones in the rapidly expanding Omega-3 Market globally. The market outlook highlights a strong shift toward plant-based innovations, sustainable sourcing, and advanced delivery formats such as Chews and fortified functional
Organic Electronics Market for Biosensing to Reach USD 352 Billion by 2035, Driven by Flexible, Wearable Healthcare Innovations
Organic Electronics Market for Biosensing to Reach USD 352 Billion by 2035, Driv …
Organic Electronics Market for Biosensing is Projected to Grow to USD 352 Billion by 2035 Organic Electronics Market for Biosensing projected to grow at a CAGR of 16.2% during the forecast period of 2025 to 2035 MarketGenics, a leading name in healthcare and electronics market research, announced a series of significant milestones highlighting the rapid expansion of the Organic Electronics Market for Biosensing worldwide. The market insights demonstrate cutting-edge innovation, breakthroughs in wearable

All 5 Releases


More Releases for Diagnostics

Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025. The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. Get Free Sample PDF Copy at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3095138. Top Key Players in the Global Covid-19 Diagnostic Market Include: - o Abbott Diagnostics o
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer
05-16-2019 | Health & Medicine
Fact.MR
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report. Get Sample Copy of this Report @